Trial Information

Summary: An experimental study to determine the dosage and safety of a study drug in patients with leukemia.

North Shore University Hospital is conducting a study to determine the safety, tolerability, and dosage of an experimental drug, in patients with leukemia.

Some of the study subject requirements are:

• Having pathologic confirmation of leukemia or myelodysplastic syndrome
• Being at least 18 years old
• Having a life expectancy of at least 12 weeks

A study subject may not participate in this study if they:

• Have had chemotherapy or other experimental anticancer treatment in the two weeks prior to study entry
• Are pregnant or breastfeeding
• Have evidence of central nervous system leukemic involvement
• Have clinically significant heart disease or lung disease
• Have active or uncontrolled infection
• Have evidence of invasive fungal infection, HIV, or hepatitis C infection
• Have a history of Wilson’s disease or other copper-related disorder
• Have a known hypersensitivity to cytarabine, daunorubicin or liposomal products

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.